Summary
TP PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,500. Its solvency ranks better than 25% of 9,624 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Activity
Other business support services
NACE 82990
1 site
Size
€8,704total assets 2025
- Equity
- €1,500
Turnover not published (micro format)
Financial health
- Bankruptcy probabilitywithin 12 months
- 0.3%
Too few figures to score
Signalsraises riskFounded in 2025Weak solvency vs sectorlowers riskSector: Office administrative, office support and other business support activities (NACE 82)Size: total assets €8,704Figures for financial year 2025 (filed 11-02-2026)neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 9624 sector peers (2025).
NBB · sector comparisonPosition among 9624 sector peers
Solvency
better than 25%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-02-2026, 171 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
171 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: PAUMEN Tim (director) ·…
Financials · financial year 2025, micro format
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€1,500
Total assets
€8,704
Net result
Not included in this filing
Working capital
€1,500
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
Equity and liabilities €8,704
Equity
€1,500
Debt
€7,204
Debt finances 82.8% of the balance-sheet total.
Key figures and ratios
Current ratio
1.21
Debt to equity
4.80
Debt ≤ 1 year
€7,204
Annual accounts
| Line | 2025 |
|---|---|
| Other operating charges640/8 | €341 |
| Gross operating margin9900 | €346 |
| Operating profit (loss)9901 | €5 |
| Financial charges65/66B | €5 |
| Recurring financial charges65 | €5 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €8,704 | |
| Current assets29/58 | €8,704 | |
| Amounts receivable within one year40/41 | €8,347 | |
| Trade receivables40 | €7,725 | |
| Other amounts receivable41 | €622 | |
| Cash at bank and in hand54/58 | €357 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €8,704 | |
| Equity10/15 | €1,500 | |
| Contributions10/11 | €1,500 | |
| Amounts payable17/49 | €7,204 | |
| Amounts payable within one year42/48 | €7,204 | |
| Trade debts44 | €2,505 | |
| Suppliers440/4 | €2,505 | |
| Other amounts payable47/48 | €4,700 | |
Not filed in this scheme.
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 10-02-2026 | 2026-00036858 |
Similar companies · same sector, comparable size
Aedifis
BE 0743.797.087
Waterloo · equity €1,500
Notariële bestuursvennootschap Helen Muylaert
BE 0734.495.678
Zemst · equity €1,500
KoMMiTment
BE 0771.498.804
Tongeren-Borgloon · equity €1,500
C.RYDBERG
BE 0765.916.651
Oudergem · equity €1,500
MEFICO
BE 0792.545.329
Antwerpen · equity €1,500
Of the 24,208 active companies whose main activity is other business support services (NACE 82990), figures are known for 9,628. 1,395 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
1 director, no change since 2025
PAUMEN Tim
CurrentDirector (not named in the articles) · since 02-10-2025
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2025, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| PAUMEN Tim |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
At incorporation
act of 06-10-2025 ↗
- PAUMEN Tim 100 shares (100%) · €1,500
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 06-10-2025 Incorporation · €1,500 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
History
Acts, filings and financial milestones
2026
10-02
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
06-10
Gazette deed
IncorporationAppointment: PAUMEN Tim (director) · Founder · Founding capital7 facts ▸
Gazette deed
Incorporation
Appointment: PAUMEN Tim (director) · Founder · Founding capital7 facts ▸
- Incorporation, 02-10-2025
- Founder, PAUMEN Tim
- Founding capital, €1,500
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Director appointment, PAUMEN Tim (director (not named in the articles))
- Bank account, “FINTRO”, 1500 (deed in Dutch)
- Power of attorney, ACCOUNTANCY KAVA
Gazette deedNBB filing
1 of 1 deed read
Register details
Identification
Legal formPrivate limited company
Founded02-10-2025
Financial year end31-12
Activities, NACEBEL 2025
82990Other business support services
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID
0208:1028516932
Also
9925:BE1028516932
Registered
06-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 25 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Zoersel · 1 establishment unit since 2025
Ground area
1,241 m²
Building footprint
210 m²
Building volume
1,192 m³
Parcel 11055D0034/00H004, Flanders · tallest building 9.1 m. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
TP PHARMA
since 2025unit no. 2.379.328.935
1 parcel
Flanders
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 11055D0034/00H004 | Flanders | 1,241 m² | 1 · 210 m² | 9.1 m · 2 |
How the parcels are linked
Good to know
The parcel matches the address exactly.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Waarnemen van de functie van apotheker provisor of adjunct-apotheker voor rekening van derden; Het oprichten, huren, overnemen en uitbaten…” (deed in Dutch)
14 activities (deed in Dutch)
- Waarnemen van de functie van apotheker provisor of adjunct-apotheker voor rekening van derden
- Het oprichten, huren, overnemen en uitbaten van apotheken: de aan en verkoop, de in- en uitvoer, de fabricatie in het groot en in het klein van scheikundige, farmaceutische en parafarmaceutische artikelen
- De handel in kruiden, drogisterij-, schoonheids-, toilet-, verband-, dieet-, laboratorium-, optische en onderhoudsartikelen en aanverwante producten of diensten
- Het ondernemen van industriële en klinische ontledingen
- Iedere handelsbedrijvigheid welke met gezondheidszorg verband houdt, in de ruimste zin genomen
- Het aan- en verkopen van allerhande kunstobjecten en antiquiteiten
- Participaties te verwerven en aan te houden, onder meer door deel te nemen aan het bestuur van de ondernemingen waarin zij participeert
- Het deelnemen in of de directie voeren over andere vennootschappen en ondernemingen
- Het management en het bestuur van om het even welke ondernemingen en vennootschappen, het optreden als vereffenaar
- Het verlenen van technisch of commerciële bijstand aan alle Belgische en buitenlandse ondernemingen
- Het verlenen van financiële bijstand
- Haar patrimonium, bestaande uit onroerende en roerende goederen, te behouden, in de ruimste zin van het woord te beheren en oordeelkundig uit te breiden
- Het aanvragen, verwerven, verhandelen en exploiteren van licenties, octrooien, merken en dergelijke
- Het beheer en de uitbreiding voor eigen rekening van een patrimonium bestaande uit roerende en onroerende goederen zowel in het binnenland als in het buitenland alsmede alle handelingen die daar rechtstreeks of onrechtstreeks verband mee houden of die van aard zijn de opbrengst van haar goederen te bevorderen, zoals de aankoop en de verkoop, huur en verhuur, de ruiling of in het algemeen de verwerving of de overdracht van goederen zo roerende als onroerende, het onderhoud, de ontwikkeling, de verfraaiing en de verhuring van goederen, met uitzondering van die verrichtingen die verband houden met de normale activiteiten uitgeoefend door vastgoedmakelaars
- Name clauseThe name the company operates under according to its articles.
- TP PHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, Zoersel, Antwerpsedreef 2” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Daily managementWho may handle the everyday running of the business without the full board.
- The board decides whether the delegates act alone or jointly
- Board ruleHow the board is made up, meets and takes decisions.
- “Met of zonder beperking van duur, 1” (deed in Dutch)
- Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
- One provision in the deed
Capital, shares and profit
- Profit allocationHow profit is distributed; a BV may only pay out after a balance-sheet and liquidity test.
- “Bestuursorgaan, algemene vergadering” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “voor derden borg stellen door haar goederen in hypotheek of in pand te geven, inclusief de eigen handelszaak. Kortom zij mag alles doen wat…” (deed in Dutch)
- Proxy ruleWhether a shareholder may be represented at the meeting by someone else.
- “Nihil” (deed in Dutch)